Includes Additional Data News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Includes Additional Data. Real-time updates on events, politics, business and more.

Allogene Therapeutics Announces Oral Presentation of Phase

June 9, 2023

Long-Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials Demonstrates Potential of Allogeneic CD19 CAR T to Generate Durable Complete Responses Similar to...

United States Christine Cassiano Madeleine Goldstein Frederick Locke Allogene Allo Moffitt Cancer Center Tampa

Source: globenewswire.com

Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) Lugano

June 9, 2023

10.06.2023 - Long-Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials Demonstrates Potential of Allogeneic CD19 CAR T to Generate Durable Complete Responses Similar to Approved Autologous TherapiesPresentation Recaps 12 Patients Treated with Phase 2 Dose ... Seite 1

United States Allogene Therapeutics Inc American Society Of Clinical Oncology International Conference On Malignant Lymphoma Long Term Follow Up Data Demonstrates Potential

Source: wallstreet-online.de

Stock Market | FinancialContent Business Page

June 9, 2023

FinancialContent fully hosted finance channel

United States Frederick Locke Madeleine Goldstein Allogene Allo Christine Cassiano Corporate Pipeline Communications

Source: financialcontent.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Includes Additional Data News Today

Allogene Therapeutics Announces Oral Presentation of Phase

Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) Lugano

Stock Market | FinancialContent Business Page

Explore More Categories